Ozempic May Work by Activating Hunger Neurons, Not…

Ozempic May Work by Activating Hunger Neurons, Not Suppressing Them, Yale Study Finds GLP-1 drugs like Ozempic have delivered a level of sustained weight loss unmatched by previous obesity medications, typically 10 to 15% or more. Yet exactly how these drugs achieve this inside the brain has remained genuinely unclear. A new Yale study, published in PNAS, overturns a long standing assumption about the mechanism involved, and the answer is almost the opposite of what researchers expected. The prevailing assumption this study challenges: Scientists have generally believed that agouti-related peptide, or AgRP, neurons, well known for driving hunger, work against weight loss, and that GLP-1 drugs succeed by suppressing these hunger signaling neurons. However, this specific mechanism had never actually been directly tested during chronic GLP-1 treatment in a living organism. Why this question mattered in the first place: Earlier generations of weight loss drugs could reduce appetite almost as effectively as semaglutide, the active ingredient in Ozempic, yet none of them produced comparably sus